SEC Form 4 · accession 0001683607-26-000014
Royalty Pharma plc · RPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bonnie L Bassler
Director
Period of report
Jun 30, 2026
Accepted (ET)
Jun 30, 2026 · 5:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001802768
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary SharesF1 | Jun 30, 2026 | A | 689 | $54.3998 | A | 79,181 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.